Blueprint Biomed has been selected as one of only six startups to join the BIH Clinical Incubator (CLIC), a program dedicated to translating groundbreaking science toward real patient impact

This milestone connects Blueprint Biomed to a world-class network of clinicians, scientists, entrepreneurs, and industry stakeholders, all operating at the intersection of research and real-world application. The program provides access to clinical infrastructure, regulatory guidance, and business expertise, critical resources to refine our technology, navigate complex approval pathways, and accelerate our journey to market.

The BIH Clinical Incubator, a collaboration between the Berlin Institute of Health at Charité and BioLabs, is designed to bridge the gap between early-stage research and patient impact. For Blueprint Biomed, participation means not only strengthening its business strategy but also validating its solution in a clinical context and ensuring alignment with real patient needs.

We look forward to collaborating with fellow innovators in this vibrant ecosystem and taking a decisive step toward delivering our solution to the patients who need it most.